To the question of prostate diseases therapy

Artifeksov S.B., Volkov D.Y., Sevryukov F.A.

State Medical Academy, Nizhny Novgorod

Therapy of chronic prostatitis is a challenge for modern medical science. It stipulates the patient and the doctor to work hard and intends application of wide range of pharmacological products. Some of them, for example, antibiotics and other anti-infective products, can cause the decrease of quality of life, including microecological disorders (dysbacteriosis) of the intestines and mucous coats of the urinogenital system, disorders of kidneys and liver function, etc. Extremely widespread polypragmasy can be referred to disadvantages of therapy of chronic prostatitis, that results in significant increase of treatment cost, but often without any vivid effect. Nowadays the researchers pay special attention to products of the combined effect that impact the main aspects of pathogenesis of chronic prostatitis. Product Bioprost® (CJSC Intelpharm ; rectum suppositories with pumpkin oil 0.5 g. and thymolum 0.1 g. and lipophilic basis up to 2 g) can be related to such pharmaceuticals.

Clinical research of efficiency of product Bioprost® has been executed at observation of 226 patients afflicted with chronic prostatitis, benign prostatic hyperplasia (BPH), and also at prevention of sharp urinary delay, that can be observed after any, even not rather serious operations. The product was prescribed per 1 suppository (candle) twice a day after manipulation and at first day after surgery. The period of application was from 3 up to 14 days. No cases of aggravation or absence of therapeutic effect caused by therapy have been revealed at assessment of therapy efficiency. 75% patients demonstrated vivid improvement of state and regression of the disease features, including the data of general, laboratory and tool examinations; hence, it was been specified as a good therapeutic result. Thus, application of product Bioprost® by the patients afflicted with chronic non-specific prostatitis and/or benign prostatic hyperplasia of the 1 degree is safe and effective both in the period of aggravation of the disease and in the period of remission. Besides, application of product Bioprost® reduces the risk degree of development of sharp urinary delay after internal urethral manipulations and urological surgeries.